3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Neoplasms
1522
Carcinoma, Non-Small-Cell Lung
757
Breast Neoplasms
572
Neoplasm Metastasis
531
Colorectal Neoplasms
447
Melanoma
391
Leukemia, Myeloid, Acute
372
Multiple Myeloma
364
Ovarian Neoplasms
354
Recurrence
336
Lymphoma
334
Advanced Solid Tumors
325
Lymphoma, Non-Hodgkin
315
Prostatic Neoplasms
300
Pancreatic Neoplasms
285
Advanced Solid Tumor
240
Stomach Neoplasms
233
Carcinoma, Renal Cell
226
Squamous Cell Carcinoma of Head and Neck
211
Lung Neoplasms
210
Solid Tumor
204
Leukemia, Lymphocytic, Chronic, B-Cell
198
Triple Negative Breast Neoplasms
184
Solid Tumors
183
Carcinoma, Hepatocellular
165
Hematologic Neoplasms
155
Head and Neck Neoplasms
153
Lymphoma, Large B-Cell, Diffuse
148
Lymphoma, Follicular
146
Glioblastoma
145
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
INDUSTRY
×
Pancreatic Intraductal Neoplasms
×
Clear all
NCT07213791
2026-06-04
FiREBOLT
Eli Lilly and Company
Phase 1
Recruiting
241 enrolled